Filarial infections are characteristically chronic and can cause debilitating diseases governed by parasite-induced innate and adaptive immune responses. Filarial parasites traverse or establish niches in the skin (migrating infective larvae), in nonmucosal tissues (adult parasite niche) and in the blood or skin (circulating microfilariae) The offspring of the adults, the microfilariae (mf), either circulate in the blood or migrate through the skin. The mf then can be ingested by the appropriate biting arthropod and develop over 1-2 weeks into infective larvae, which are capable of initiating the life cycle over again.
responses early in infection are often modulated over time by both adaptive and natural regulatory T cells, regulatory monocytes/macrophages (Mregs) and B cells (Breg), eosinophils and other cell populations that have been postulated to reflect an IL-10 dominated milieu. 11 Humans are the definitive host for each of the filarial parasites.
Several nonhuman primate species (eg, chimpanzees and mangabey monkeys for O. volvulus, the silver leaf monkey for W. bancrofti, rhesus monkeys and baboons for L. loa) have been shown to be fully permissive to these infections, 12 but none of the eight species that infect humans is fully permissive in immuocompetent mice.
Therefore, animal models of filarial infections are limited to infection models with Brugia and the rodent filarial parasite Litomosoides sigmodontis. 13 Although the small animal models of filariasis do not fully recapitulate disease or the natural life cycle of filarial infections in humans, these models have been integral in the examination of both innate and adaptive immune responses to filarial parasites. [14] [15] [16] Infection with L. sigmodontis begins with injection of the L3 stage parasite, which migrates through the thoracic cavity and develops into adult parasites that take residence in the pleural cavity. Infected mice are able to achieve patency, releasing mf into the blood. The life cycle of both human and murine filarial parasites shares many similar anatomical locations in which different parasite stages intersect with the host immune response (Table 1) . These immunological intersection points can vary in duration from several days, as L3 transit through the skin, to months to years, as mf are released and circulate in the blood or skin. Furthermore, the longevity of adult parasites can persist in the lymphatics or skin nodules for several years. The presence of parasites and circulating parasite antigens results in significant systemic immune alterations.
Filarial parasites exert profound regulatory effects on the host with both parasite antigen-specific and more generalized levels of immune modulation. It has been shown that patients with patent filarial infection have markedly diminished responses to parasite antigens 11, 17 ; in addition, these parasites also can induce attenuated responses to nonhelminth antigens [18] [19] [20] [21] including those that are delivered as approved vaccines. [22] [23] [24] [25] [26] The chronicity of many of these filarial parasites is presumed to reflect successful immune evasion strategies that allow these parasites to avoid elimination 27 ; this immune evasion is often dependent on the modulation of the parasite-specific host inflammatory responses.
In the process of establishing a patent infection, the infectious stages must traverse a set of barriers the cells of which form an innate interface that can serve to modulate/induce certain immune or inflammatory functions. This review centres primarily on the interaction between the parasite stages (at their various anatomic niches) and the ILCs that are found at these sites. For the most part, the focus will be on human ILCs given that most of the filarial parasites have humans as their only definitive host.
As is already well-known, ILCs are potent cytokine producers that respond to alarmins and stress indicating molecules released by barrier 
| INNATE LYMPHOID CELLS

| HUMAN ILCS IN TISSUE AND IN THE PERIPHERAL BLOOD
| ILCs in cutaneous tissue
The skin is a critical barrier between microbes and the host, and
ILCs are among many immune cells that reside in the skin. 57, 58 The cutaneous ILC composition in healthy adults consist of NK cells, helper ILC1s, ILC2s as well as NKp44-and NKp44+ILC3s 58, 59 ( Table 2 ). Evidence of conversion of cutaneous NKp44-ILC3s into NKp44+ILC3s has been demonstrated through ex vivo cultures in the presence of IL-2, IL-23 and IL-1β. 59 In situ analysis of the anatomical localization of ILC subsets in the skin and has revealed the absence of ILCs in the epidermis and the hypodermal layers.
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The majority of cutaneous ILCs were located in the upper dermal layer of the skin, although healthy skin contained very few human 
| ILCs in lymphatic tissue
At homoeostasis, ILCs also reside in the secondary lymphoid tissues (reviewed in reference62) such as the spleen, 63 
| ILCs in peripheral blood
Human ILCs can be found in both mucosal and nonmucosal tissues 71 although the frequency and heterogeneity of ILC subsets differ between mucosal and nonmucosal tissues. 60 Multiple studies evaluating ILC subsets in the peripheral blood of humans have identified the presence of ILC1s, ILC2s and NKp44-ILC3s in circulation. 59, 72 NKp44+ILC3s, in contrast have not been found in the peripheral blood of healthy human donors. 
All helper ILC subsets found in the periphery have also been
shown to express the skin homing marker cutaneous lymphocyte antigen (CLA) 58, 59 and, to a lesser extent, the skin homing chemokine CCR10. 59 The expression of skin homing markers under homoeostatic conditions suggests that ILCs found in circulation can migrate to skin or other tissues and their presence in the peripheral blood may be short lived. 
| INNATE IMMUNE RESPONSE DURING FILARIAL INFECTIONS
| Cutaneous innate cells during filarial parasites
| Lymphatic endothelial cells during filarial infections
The lymphatics represents the anatomical niche for the adult parasites for three of the eight filarial species, yet the area surrounding the parasites are often devoid of inflammatory cells. Secondary lymphoid tissue includes the following: tonsil, lymph node and spleen % average percent of ILC subsets from total ILCs.
| ILCS DURING FILARIAL INFECTIONS
| Murine filarial infections
Murine models of helminth infections played a central role in the identification of ILCs and defining the role of ILC2 subsets in the initiation and development of the Th2 response as well as the expulsion and clearance of parasites during Heligmosomoides polygyrus 80 and
Nippostrongylus brasiliensis 81, 82 infections. In addition to the protective role of murine ILC2s during helminth infections, ILC2s can also have a deleterious effect on pulmonary fibrosis, as demonstrated using the Schistosoma mansoni egg-induced pulmonary granuloma model. 83 The well-described murine model of L. sigmodontis has highlighted similarities between the human and mouse immune response to filarial parasites including the progressive loss in Th2 cytokines by CD4+ T cells, 15 an elevation in IL-10 16 and the induction of T regulatory cells 14 that maintain a T-cell hyporesponsive state. 15 ILC2 populations were shown to be expanded during the Th2-dominated L. sigmodontis infection. 84 The expansion of these cells occurred just prior to patency and was localized to the pleural cavity the future niche of adult para- 
| Human filarial infections
In contrast, to the murine helminth models of infection that were used to first identify and define the role of helper ILC2s 
| Nonfilarial helminth infection and ILCs
As many of the helminth infections occur in children, understanding the role of the ILCs in children remains a relatively unexplored area of
interest. An analysis of ILCs in human cord blood and adult peripheral blood did reveal that the frequency of ILC2s and NKp44-ILC3s was higher in cord blood than in the adult peripheral blood. The distribution of cytotoxic and helper ILC1s was unquantifiable in this study, as they were undistinguishable from NK and other cell populations. Taken together these findings indicate that ILC2s are also susceptible to the post-treatment reversal of the IL-10-mediated immunosuppression, previously described for both filariasis 103 and schistosomiasis. 
